Antiandrogen-Estrogen Therapy for Signs of Androgenization / / ed. by Adolf E. Schindler.

• Superior document: Title is part of eBook package: De Gruyter DGBA Medicine and Life Sciences - <1990
• MitwirkendeR: Abbate, R.,; Ashton, R. E.,; Aydinlik, S.,; Baglioni, A.,; Bertolini, S.,; Bonnivert, J.,; Brummitt, L.,; Bruni, V.,; Bucciantini, S.,; Burke, B.,; Capitanio, G. L.,; Carinelli, S. G.,; Carlborg, L.,; Casarotti, G. A.,; Cecco, L. De,; Centonze, A.,; Croce, S.,; Crona, N.,; Cunliffe, W. J.,; Davies, T. G.,; Dowd, P. M.,; Emonts, P.,; Enk, L.,; Ernst, E.,; Falsetti, L.,; Farquhar, D. J.,; Fedele, L.,; Flamigni, C.,; Fugère, P.,; Gaspard, U. J.,; Gastaldi, A.,; Gillain, D.,; Greenwood, R.,; Griffiths, W. A. D.,; Haspels, A. A.,; Higgins, H. P.,; Hirvonen, E.,; Huber, J.,; Hutchinson, P. E.,; Jacobs, H. S.,; Kaiser, E.,; Lachnit-Fixson, U.,; Lambotte, R.,; Lindberg, U.-B.,; Lussier-Cacan, S.,; Marchini, M.,; Matrai, A.,; Miller, J. A.,; Neumann, F.,; Nürnberger, F.,; O’Brien, T. J.,; Percival-Smith, R. K. L.,; Pinto, S.,; Rosati, D.,; Rubens, R.,; Samsioe, G.,; Schindler, A. E.,; Schmidt, J. B.,; Schmölzl, Ch.,; Schramm, W.,; Silfverstolpe, G.,; Spona, J.,; Stenman, U.-H.,; Täuber, U.,; Tétrault, C.,; Vange, N. van der,; Vartiainen, E.,; Vermeulen, A.,; Verni, A.,; Wojnarowska, F. T.,; Zamberletti, D.,; Zurth, Chr.,
• HerausgeberIn: Schindler, Adolf E.,
• Place / Publishing House: Berlin ;, Boston : : De Gruyter, , [2019]; ©1987
• Year of Publication: 2019
• Edition: Reprint 2019
• Language: English
• Series: New Developments in Biosciences ; 3
• Physical Description: 1 online resource (244 p.)

Table of Contents

Frontmatter -- Welcome address -- Contents -- Introduction -- Antiandrogen therapy for signs of androgenization: an overview -- I. Pharmacology and physiology -- Pharmacological aspects of cyproterone acetate -- Pharmacokinetics of cyproterone acetate and ethinyl estradiol in smoking and non-smoking women during treatment with Diane-35 -- Ovulation inhibitory effect of SH B 209 AE (Diane-35)—a new antiandrogen-estrogen combination -- A study to investigate the maintenance of ovulation inhibition when patients switch over from Diane to Diane-35 -- Effect of a new antiandrogen-estrogen sub-fifty combination on the endometrium -- II. Polycystic ovary syndrome -- Endocrinological and clinical findings on the therapy with Diane-35 in polycystic ovary syndrome -- Discussion -- III. Effects on the haemostatic system -- Longitudinal study on the effects of a cyproterone acetate and ethinyl estradiol combination on haemostasis -- Haemorheological effects of Diane-35 and Microgynon®—Preliminary results of a double blind study -- Antiandrogen treatment in women with acne: a controlled trial -- IV Special aspects -- Clinical assessment of two antiandrogen treatments, cyproterone acetate combined with ethinyl estradiol and spironolactone in hirsutism -- Treatment of severe androgenization symptoms with Diane and intramuscularly applied cyproterone acetate (Androcur Depot) -- One-year experience with a new oral contraceptive using natural estradiol and cyproterone acetate -- Discussion -- V. Metabolic and clinical aspects -- Clinical and metabolic effects of a new estrogenantiandrogen low dose combination -- Effects of cyproterone acetate on serum lipoproteins when administered alone and in combination with ethinyl estradiol -- Clinical, metabolic and endocrine effects of long term use of a cyproterone acetate and ethinyl estradiol combination in hyperandrogenized women -- Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne : results of a multi-center study -- Comparison of Diane-35 with Neo-Eunomin from the dermatological viewpoint -- A double blind comparative study of tetracycline and Diane, alone and in combination in the treatment of acne -- The comparative efficacy and safety of Diane- 35 versus Diane-50 in the treatment of moderate to severe acne and seborrhea: preliminary results -- Results of an extended open phase m study with Diane-35 -- Discussion -- Closing remarks -- List of first-mentioned contributors